TP53 and cancer: It is well recognized that almost all serous ECs occur with a TP53 mutation which plays an important role in G1/S and G2/M cell-cycle checkpoint regulation in response to DNA damage, thereby permitting normal and cancer cells to repair damaged-DNA before entering the S and G2 phases.